Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation

NCT: NCT07753434 · COMPLETED

NCT IDNCT07753434
StatusCOMPLETED
Start Date2024-08-01
Completion2025-02-27
SponsorThe Second Affiliated Hospital of Chongqing Medical University (OTHER)
First posted
Last updated

Brief Summary

This observational study aims to explore the predictive value of intraoperative laser speckle contrast imaging for early postoperative renal function in kidney transplant recipients. The core research question is: What is the efficacy of intraoperative laser speckle contrast imaging in predicting early postoperative renal function among kidney transplant patients? This study will enroll kidney transplant patients who undergo intraoperative laser speckle contrast imaging and collect relevant evaluation data. Last updated on February 27, 2025

Frequently Asked Questions

What is Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation?

Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation is a clinical trial registered under NCT07753434. Current status: COMPLETED.

What is the status of NCT07753434?

The current status of NCT07753434 (Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation) is: COMPLETED.

When did Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation start?

Intraoperative Laser Speckle Imaging Predicts Early Renal Function After Kidney Transplantation started on 2024-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.